Braveheart Bio, Inc.

Nasdaq: BRVEDefensive candidate

65 days public · Pharmaceutical Preparations · $20.02 (+4.87%)

Defensive candidate RANKED

/ 100 fit

Confidence100%

Braveheart Bio, Inc. (BRVE) received a Defensive strategy-fit score of 46 out of 100 based on fundamental constraints offset by strong institutional alignment and reporting activity.

Intelligence score

/ 100 core

Suggested alloc

20%

cap · your limits

Days public

EARLY PUBLIC

Last price

$20.02

live quote

1d change

+4.87%

session

Why selectedLIVE

EQUENCY Reasoning Engine

+High institutional stability demonstrated by 4,3 Schedule 13D/13G disclosures on file with the SEC, resulting in an institutional sub-score of 93.
+Active corporate governance and filing narrative with 2,8-K filings and 29 insider forms submitted to the SEC, yielding a narrative sub-score of 78.
+Short-term positive momentum with a 1-day price move of plus 4.87 percent, contributing to a momentum sub-score of 60.

RisksLIVE